reference/7963826

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7963826

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	795
issn	1555-8576 1538-4047
issueIdentifier	8
pageRange	788-795
publicationName	Cancer Biology & Therapy
startingPage	788
bibliographicCitation	Hu S, Yu L, Li Z, Shen Y, Wang J, Cai J, Xiao L, Wang Z. Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo. Cancer Biol Ther. 2010 Oct 15;10(8):788–95. doi: 10.4161/cbt.10.8.12913. PMID: 20686362.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_981785e990278d4f8be89531d53e2374 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_523e6a2a3c6f84e93084fb6be0eadf1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7eb8d1b1c1d413e21fdc0a5f58693d72 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f69dbe105bd7243bf0f4dcd3665251b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f24d976d62f793828e5da8f2b7ca5d45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d125c45ced1bd34b2d971970a460b6c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_459a407e80e92926051c268b6f70c217 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f534897dc2d9c6ac2739a67dd2cb713
date	2010-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.4161/cbt.10.8.12913 https://pubmed.ncbi.nlm.nih.gov/20686362
isPartOf	https://portal.issn.org/resource/ISSN/1555-8576 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/29779 https://portal.issn.org/resource/ISSN/1538-4047
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
discusses	http://id.nlm.nih.gov/mesh/M000613664 http://id.nlm.nih.gov/mesh/M0499463 http://id.nlm.nih.gov/mesh/M0010429 http://id.nlm.nih.gov/mesh/M0004505 http://id.nlm.nih.gov/mesh/M0006678 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0012835 http://id.nlm.nih.gov/mesh/M0021788 http://id.nlm.nih.gov/mesh/M0442870
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014157Q000235 http://id.nlm.nih.gov/mesh/D002945Q000494 http://id.nlm.nih.gov/mesh/D015972 http://id.nlm.nih.gov/mesh/D010051Q000188 http://id.nlm.nih.gov/mesh/D019008Q000235 http://id.nlm.nih.gov/mesh/D004268Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D014157Q000378 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D008745Q000187 http://id.nlm.nih.gov/mesh/D015153 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D034622 http://id.nlm.nih.gov/mesh/D047368Q000235 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D047368Q000187 http://id.nlm.nih.gov/mesh/D004268Q000378 http://id.nlm.nih.gov/mesh/D002470Q000235 http://id.nlm.nih.gov/mesh/D006657Q000378 http://id.nlm.nih.gov/mesh/D010051Q000473 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D010051Q000235 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D020133 http://id.nlm.nih.gov/mesh/D000071221 http://id.nlm.nih.gov/mesh/D063151 http://id.nlm.nih.gov/mesh/D008239Q000378 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D002470Q000187
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c3addd02e769f33d86f94bb13502ccd5 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5962 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676225 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2146 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368393

Total number of triples: 77.